Newsmeme!
Discover News you didn't know existed
While the glitz and glamour of homecoming raged outside of New Caney’s locker room, the Eagles gathered inside to pay homage to one of their biggest fans.
A simulated gastrointestinal system is helping scientists test contaminated soil for its potential to harm humans. The method is likely to save time and money for people hoping to repurpose land with an industrial past. Most testing for potential arsenic exposure is conducted in recognition of a dirty little secret of modern life: Humans unknowingly eat a little bit of soil each day. For ...
MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of viral respiratory infection among preterm infants.
An early proof-of-concept study presented shows promising results for imatinib in the treatment of pulmonary arterial hypertension (PAH), a severe, incurable blood vessel disorder.
Urinary incontinence and pelvic prolapse are among the most common and least discussed women's health issues.
Bacteria in your gut makes you smarter, slims you down and keeps you healthy. It also gives you allergies, aids diabetes and causes cancer. It's a delicate balance between keeping you strong and making you sick that science knows little about.
Most people know that chocolate is dangerous for cats and dogs, but there are a number of other human foods to keep away from pets — even some it’s hard to imagine them wanting in the first place.
SAN FRANCISCO, Oct. 10, 2008 -- NiTi Surgical Solutions, a privately-held company focused on advancing medical technologies for gastrointestinal surgery, today announced that the NiTi Compression Anastomosis Ring, a new device that reconnects tissues naturally after colorectal surgery, has been used in 500 colorectal surgical procedures.
Title: Infliximab-Based Treatment Effective for Crohn's Patients Category: Health News Created: 10/10/2008 2:00:00 AM Last Editorial Review: 10/10/2008
Berlin, 7 October 2008 – Firazyr® (icatibant), the first subcutaneous symptomatic treatment for acute attacks of hereditary angioedema (HAE) in adults (with C1-inhibitor-deficiency), is now available in the UK. Firazyr® blocks oedema formation in all types of HAE attacks.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |